Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Leukaemia in Relapse”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT03957915
What this trial is testing

Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia RecurrentAcute Lymphoblastic Leukemia, in RelapseAcute Myeloid Leukemia, in Relapse+2 more
Institut Paoli-Calmettes 33
Testing effectiveness (Phase 2)Study completedNCT03384654
What this trial is testing

Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Janssen Research & Development, LLC 47
Testing effectiveness (Phase 2)Ended earlyNCT01880437
What this trial is testing

Vismodegib in Patients With Relapsed/Refractory Acute Myelogenous Leukemia and Relapsed Refractory High-Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes, Myelogenous Leukemia, Acute
Hoffmann-La Roche 38
Early research (Phase 1)Study completedNCT02561988
What this trial is testing

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

Who this might be right for
Aggressive Systemic MastocytosisSystemic Mastocytosis-associated Hematologic Non-mast Cell DiseaseMast Cell Leukemia+1 more
Blueprint Medicines Corporation 86
Early research (Phase 1)Looking for participantsNCT06651229
What this trial is testing

JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Neoplasms
Janssen Research & Development, LLC 155
Testing effectiveness (Phase 2)Ended earlyNCT05032183
What this trial is testing

Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
Recurrent Adult Lymphoblastic LymphomaRecurrent B Acute Lymphoblastic LeukemiaRecurrent T Acute Lymphoblastic Leukemia+3 more
M.D. Anderson Cancer Center 4
Early research (Phase 1)Study completedNCT04543305
What this trial is testing

PRT1419 in Patients With Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Multiple MyelomaAcute Myeloid LeukemiaNon Hodgkin Lymphoma+1 more
Prelude Therapeutics Incorporated 16
Testing effectiveness (Phase 2)Study completedNCT00010283
What this trial is testing

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00003673
What this trial is testing

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

Who this might be right for
Leukemia
Pfizer 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT05029141
What this trial is testing

New Double Epigenetic Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRefractory Acute LeukemiaRelapsed Adult AML
The First Affiliated Hospital of Soochow University 21
Early research (Phase 1)Study completedNCT00258271
What this trial is testing

Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
University of Rochester 18
Early research (Phase 1)Not Yet RecruitingNCT07432100
What this trial is testing

Clinical Study on the Safety, Efficacy and Pharmacokinetics of Universal CLL1 Chimeric Antigen Receptor T-Cell in Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaChimeric Antigen Receptor T-cellUniversal CLL1 CAR-T
Mingfeng Zhao 20
Early research (Phase 1)Study completedNCT00022451
What this trial is testing

Tipifarnib in Treating Young Patients With Refractory Leukemia

Who this might be right for
Leukemia
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Ended earlyNCT00939653
What this trial is testing

T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)

Who this might be right for
Relapsed Acute Myelogenous Leukemia
Therapeutic Advances in Childhood Leukemia Consortium 6
Early research (Phase 1)Ended earlyNCT02848911
What this trial is testing

Safety Study to Assess AFM11 in Patients With Relapsed or Refractory Adult B-precursor ALL

Who this might be right for
Leukemia, B-Cell
Affimed GmbH 17
Early research (Phase 1)Ended earlyNCT02267863
What this trial is testing

APTO-253 in Patients With Relapsed or Refractory AML or MDS

Who this might be right for
Acute Myelogenous Leukemia in RelapseAcute Myelogenous Leukemia, Relapsed, AdultAcute Myelogenous Leukemia, Adult+2 more
Aptose Biosciences Inc. 21
Testing effectiveness (Phase 2)UnknownNCT00271063
What this trial is testing

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia
Callisto Pharmaceuticals 34
Testing effectiveness (Phase 2)UnknownNCT01039363
What this trial is testing

Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Samsung Medical Center 27
Testing effectiveness (Phase 2)Study completedNCT02937662
What this trial is testing

Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AML

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Early research (Phase 1)Study completedNCT00004047
What this trial is testing

Chemotherapy in Treating Patients Who Have Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Daiichi Sankyo
Next Page